Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials

Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials

(2013) Markus Koesters et al.   BRITISH JOURNAL OF PSYCHIATRY

A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline

(2013) Koen Demyttenaere et al.   CNS SPECTRUMS

Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression

(2013) Dan J Stein et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus

(2013) D. Karaiskos et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial

(2013) Emmanuelle Corruble et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Anhedonia and major depression: The role of agomelatine

(2012) Massimo Di Giannantonio et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Antidepressant efficacy of agomelatine versus SSRI/SNRI

(2012) Siegfried Kasper et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Sponsorship, Antidepressant Dose, and Outcome in Major Depressive Disorder

(2012) Mark Sinyor et al.   JOURNAL OF CLINICAL PSYCHIATRY

Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder

(2012) Giovanni Martinotti et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The Antidepressant Agomelatine in Daily Practice: Results of the Non-Interventional Study VIVALDI

(2012) G. Laux et al.   PHARMACOPSYCHIATRY

A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression

(2011) Robert H. Howland   DRUG SAFETY

Agomelatine: A narrative review

(2011) Koen Demyttenaere   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Agomelatine for the treatment of major depressive disorder

(2011) Regina M Carney et al.   EXPERT OPINION ON PHARMACOTHERAPY

Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients

(2011) Maria-Antonia Quera-Salva et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal

(2011) Surendra P. Singh et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Novel melatonin-based therapies: potential advances in the treatment of major depression

(2011) Ian B Hickie et al.   LANCET

Agomelatine in the Treatment of Major Depressive Disorder

(2010) Sidney H. Kennedy et al.   CNS DRUGS

The use of antidepressants in clinical practice: focus on agomelatine

(2010) R. H. McAllister-Williams et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study

(2010) Anthony Hale et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Altered expression of circadian rhythm genes among individuals with a history of depression

(2010) Jean-Philippe Gouin et al.   JOURNAL OF AFFECTIVE DISORDERS

Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder

(2010) Siegfried Kasper et al.   JOURNAL OF CLINICAL PSYCHIATRY

Agomelatine in the Treatment of Major Depressive Disorder

(2010) Stephen M. Stahl et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder

(2010) John Zajecka et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?

(2009) Stuart A. Montgomery et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Agomelatine Prevents Relapse in Patients With Major Depressive Disorder Without Evidence of a Discontinuation Syndrome

(2009) Guy M. Goodwin et al.   JOURNAL OF CLINICAL PSYCHIATRY

Does Study Design Influence Outcome?

(2009) Bret R. Rutherford et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Beyond the monoaminergic hypothesis: Agomelatine, a new antidepressant with an innovative mechanism of action

(2009) Siegfried Kasper et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

A Double-Blind Comparison of Sexual Functioning, Antidepressant Efficacy, and Tolerability Between Agomelatine and Venlafaxine XR

(2008) Sidney H. Kennedy et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY